About 600 results
Open links in new tab
  1. What is Macular Degeneration? - AMDF

    Macular Degeneration is the leading cause of vision loss, more than cataracts and glaucoma combined. It is considered an incurable eye disease, but it is treatable.

  2. Learn About Types and Stages of Macular Degeneration

    Learn about the two main types of age-related macular degeneration and the different stages of each type and how they progress.

  3. Macular Degeneration Overview | Quick Summary by AMDF

    Learn about macular degeneration and how it leads to vision loss in this quick, easy-to-understand, overview of age-related macular degeneration

  4. About Macular Degeneration - Symptoms, Risks, and Diagnosis

    Macular degeneration is a leading cause of loss of vision for older adults. Learn more about the disease and what you can do about it.

  5. The American Macular Degeneration Foundation (AMDF)

    The American Macular Degeneration Foundation Here to help you learn about and live with Age-related Macular Degeneration (AMD), offering you healthy living tips, the latest information, …

  6. 2025 AMD Awareness Month Resources - Macular

    AMD Awareness Month, sometimes also referred to as AMD and Low Vision Awareness Month, was established in 2008 to raise awareness about the national prevalence and impact of age …

  7. Dry Macular Degeneration Treatments - AMDF

    Macular degeneration treatment breakthroughs inspire hope that someday we may see a cure to this disease. Promising treatments, described below, depend upon the stage of disease …

  8. Macular Degeneration Symptoms - Know What to Look For

    Age-related macular degeneration symptoms are often detected in an eye exam, BEFORE the symptoms become noticeable to the patient.

  9. Donate to the American Macular Degeneration Foundation

    Donate today to support macular degeneration education, research, awareness, and advocacy and improve the lives of those impacted by macular degeneration.

  10. clinical trials | American Macular Degeneration Foundation

    NORTHAMPTON, Ma., Dec. 19, 2023 — The American Macular Degeneration Foundation received news that the first patient has been dosed in a safety and efficacy clinical trial of a …